丰原药业：控股股东及其一致行动人拟转让5.1%公司股份

Core Viewpoint - Fengyuan Pharmaceutical (000153) announced on August 11 that its controlling shareholder, Fengyuan Group, along with its concerted party, Ma'anshan Fengyuan Enterprise Management Co., Ltd., signed a share transfer agreement with Hainan Guihe Dayi Investment Partnership (Limited Partnership) to transfer a total of 5.1% of the company's shares at a price of 6.72 yuan per share, amounting to a total consideration of 159 million yuan [1]. Group 1 - The share transfer involves a total of 5.1% of Fengyuan Pharmaceutical's shares [1]. - The agreed transfer price is 6.72 yuan per share [1]. - The total transaction value is 159 million yuan [1].